On innovation, both as a critical tool for unmet needs, and in the battle against big pharma.
Driving innovation is a critical piece of the drug discovery jigsaw for all pharmaceutical and biotech companies. But what does that really mean on the shop floor? And, critically, how can investment in innovation be supported in these lean times?
In this interview, Raafat talks with Victoria Newing about:
Compliance issues for SMEs, and how to overcoming them
Defining and focussing your innovation process
Do M&As hinder innovation, or help it?
Innovation as competitive edge
Link to this comment:
All Comments (0)